Persson U - Search Results

1

Local treatment pattern versus trial-based data: a cost-effectiveness analysis of drotrecogin alfa (activated) in the treatment of severe sepsis in Sweden.

Hjelmgren J, Persson U, Tennvall GR. Hjelmgren J, et al. Among authors: persson u. Am J Ther. 2005 Sep-Oct;12(5):425-30. doi: 10.1097/01.mjt.0000141605.27943.8d. Am J Ther. 2005. PMID: 16148428

2

The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden.

Hjelmgren J, Ceberg J, Persson U, Alvegård TA. Hjelmgren J, et al. Among authors: persson u. Acta Oncol. 2003;42(3):218-26. doi: 10.1080/02841860310000386. Acta Oncol. 2003. PMID: 12852698

3

Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses.

Persson U, Tennvall GR, Andersson S, Tyden G, Wettermark B. Persson U, et al. Pharmacoeconomics. 1992 Dec;2(6):500-8. doi: 10.2165/00019053-199202060-00008. Pharmacoeconomics. 1992. PMID: 10147007

4

Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.

Bergman A, Hjelmgren J, Ortqvist A, Wisløff T, Kristiansen IS, Högberg LD, Persson KM, Persson U. Bergman A, et al. Among authors: persson u, persson km. Scand J Infect Dis. 2008;40(9):721-9. doi: 10.1080/00365540802014872. Scand J Infect Dis. 2008. PMID: 18712627

5

[Health services need knowledge of how the public values health].

Persson U, Hjelmgren J. Persson U, et al. Lakartidningen. 2003 Oct 23;100(43):3436-7. Lakartidningen. 2003. PMID: 14626774 Swedish. No abstract available.

6

Estimating the value of novel interventions for Parkinson's disease: an early decision-making model with application to dopamine cell replacement.

Hjelmgren J, Ghatnekar O, Reimer J, Grabowski M, Lindvall O, Persson U, Hagell P. Hjelmgren J, et al. Among authors: persson u. Parkinsonism Relat Disord. 2006 Oct;12(7):443-52. doi: 10.1016/j.parkreldis.2006.04.006. Epub 2006 Jun 22. Parkinsonism Relat Disord. 2006. PMID: 16798054 Free article.

7

The economic costs of acute myeloid leukemia in Sweden.

Tennvall GR, Persson U, Nilsson B. Tennvall GR, et al. Among authors: persson u. Int J Technol Assess Health Care. 1994 Fall;10(4):683-94. doi: 10.1017/s0266462300008266. Int J Technol Assess Health Care. 1994. PMID: 7843888

8

[Economic analysis of self treatment with desmopressin. Nasal spray in bleeding. Cost saving].

Tennvall GR, Persson U. Tennvall GR, et al. Among authors: persson u. Lakartidningen. 1995 Feb 8;92(6):523-5. Lakartidningen. 1995. PMID: 7853933 Swedish. No abstract available.

9

Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.

Borg S, Persson U, Allikmets K, Ericsson K. Borg S, et al. Among authors: persson u. Clin Ther. 2006 Nov;28(11):1947-59. doi: 10.1016/j.clinthera.2006.11.013. Clin Ther. 2006. PMID: 17213015

10

Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.

Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M. Ghatnekar O, et al. Among authors: persson u. Clin Ther. 2008 Sep;30(9):1704-13. doi: 10.1016/j.clinthera.2008.09.003. Clin Ther. 2008. PMID: 18840377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters